BRAINTREE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, is continuing its transition into a commercially focused company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results